Articles by Julian Upton - Pharmaceutical Executive


Articles by Julian Upton

OTC Drug Advertising: Alfred Hitchcock Style

Sep 1, 2014

The legendary director's on-screen attitude to his TV show's sponsor, Bristol-Myers, caused some consternation—until the drugmaker saw the results.

Pharm Exec's Annual Industry Outlook 2014

Jan 21, 2014

For Big Pharma, the merits of strategic focus and operational discipline are more important than ever. It is time to be decisive — muddling through is so yesterday.

Opening the Patent Box

Jun 1, 2013

Are the answers to the UK pharma sector's problems to be found in the government's new "Patent Box?"

Is That VBP on the Horizon, or a Mirage?

May 1, 2013

Value-based pricing in the United Kingdom is getting closer, but it remains out of focus.

Turkey: A Promise Restored?

Feb 1, 2013

After a decade of strife, the dialogue between industry and government appears to have entered a positive new phase. Julian Upton reports.

Takeda: Ignoring the 'I' in BRIC

Oct 3, 2012

Takeda's new $96 million plant in Russia is further proof of its expansive efforts to catch up in the BRIC countries. That is, the BRIC countries minus India. Chief Commercial Office Dr Frank Morich explains.

Brand Building—Not!

Aug 1, 2012

As a drug company promoting a drug free Olympiad, GSK wins our gold hands down for finally putting the industry's best face forward on the last frontier of advertising—the TV sets of Europe.

Value-Based Pricing: Too High a Price for UK Pharma?

May 1, 2012

Will changes to the P&R system in the UK finally put some real metrics behind the elusive concept of value?

Pharma Worst Hit by 'Talent Crunch'

Feb 24, 2012

A recent global CEO report reveals that 51% of pharma CEOs think it has become more difficult to hire workers within the sector, outweighing the same problem in all other industries surveyed.


Click here